Sartorius reported EUR3.43B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 12.78M 11.98M Sep/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
IQVIA Holdings USD 14.82B 1.12B Sep/2026
Moderna USD 3.55B 2.95B Sep/2026
Organon & Co USD 8.49B 6M Sep/2026
Revvity USD 2.63B 968K Sep/2026
Sartorius EUR 3.43B 216.6M Sep/2026
Tectonic Therapeutic USD 17K 26K Mar/2026
Viatris USD 11.59B 24.9M Sep/2026
Xeris Pharmaceuticals USD 189.71M 906K Sep/2026